Monday, March 28, 2011

Florida Psychiatrist Ordered to NOT Treat Women


Psychiatrist James A. Yelton Rossello is accused of molesting female inmates. See story below.

Comments can be made here: http://tinyurl.com/florida-psychiatrist

The Florida Department of Health is pursuing further action against Yelton Rossello.

The order from the Department of Health can be found here: http://www.psychsearch.net/public_records.html

U.S. Rep. Richard Nugent says Yelton Rossello should face further investigation.


St. Petersburg Times

Florida restricts license of ex-Hernando jail psychiatrist accused of molesting female inmates

By John Woodrow Cox

March 28, 2011

BROOKSVILLE — The Florida surgeon general has restricted the license of a former Hernando County jail psychiatrist after authorities say he asked female inmates to expose themselves, give him a lap dance or a kiss and implied he would trade medication for sex.

In one instance, authorities said, Dr. James A. Yelton Rossello, 53, pinned a woman to the wall and molested her.

The accusations against Yelton stem from his treatment of four female inmates from November 2009 to August 2010. During that time, the state records show, he was employed by the Corrections Corporation of America, which for 22 years was contracted to run the county jail.


Psychotropic Drug Use in Foster Care

Psychotropic Drug Use in Foster Care

In June of 2010, the US Senate Subcommittee on Federal Financial Management asked the Government Accountability Office (GAO), the investigatory arm of the Federal Government, to investigate the prevalence of prescribed psychotropic medications for children in foster care.

According to a number of foster care experts, children in foster care, who are typically concurrently enrolled in Medicaid, are three or four more times as likely to be on antipsychotic medications than other children on Medicaid. A Texas study from 2004 showed that 34.7 percent of foster children were prescribed at least one psychotropic drug with some children taking five or more.

Foster care parents receive more money if a child is on psychiatric drugs; the children are considered "special needs" children, needing a higher level of care.

Unfortunately, psychiatric drugs are not "care." Prescribing psychotropic drugs for children is especially troubling given their addictive nature and the potential side effects associated with them, including the increased risk of suicidal and violent behavior.

The Atlanta Journal-Constitution reports that House Bill 23 in the Georgia state legislature proposes to create an independent clinic review of the drugs foster children are given, which has support from both Democrats and Republicans because of its efforts to protect the vulnerable. Projections are that it will save the state millions of dollars, as Georgia spends $7.87 million per year in Medicaid funds on mind-altering psychiatric drugs for foster children.

Click here for more information about the side effects of psychiatric drugs.

Download the report "Drugging Foster Care Children" from the CCHR St. Louis website.

If you are aware of foster care children being abused by psychiatric drugs, please report this to CCHR and to the GAO.

 

 

 

Monday, March 07, 2011

Antidepressants often used for no valid reason

Antidepressants often used for no valid reason

Research published January 25, 2011 in the Journal of Clinical Psychiatry ("Antidepressant Use in the Absence of Common Mental Disorders in the General Population") concludes that "antidepressant use among individuals without psychiatric diagnoses is common in the United States," and these drugs are more likely to have been prescribed by family doctors than by psychiatrists.

Reuters picked up the story and said that "more than a quarter of people in the United States who take antidepressants have never been diagnosed with any of the conditions the drugs are typically used to treat."

At $10 billion per year, the sale of antidepressants is a major contributor to the high cost of health care insurance. As these drugs often have devastating side effects, they are calculated to create patients-for-life; more and more health care is needed to combat these side effects, while the original symptoms for which they may have been prescribed go undiagnosed and untreated.

The New York Times says (March 5, 2011) that "Talk Doesn't Pay, So Psychiatry Turns to Drug Therapy." "Psychiatric hospitals that once offered patients months of talk therapy now discharge them within days with only pills. ... A psychiatrist can earn $150 for three 15-minute medication visits compared with $90 for a 45-minute talk therapy session." Yet, "Recent studies suggest that talk therapy may be as good as or better than drugs in the treatment of depression."

Sure, people can have difficult problems in their lives, and at times they can be mentally unstable, subject to unreasonable depression, anxiety or panic. Mental health care is therefore both valid and necessary. However, the emphasis must be on workable mental healing methods that improve and strengthen individuals and thereby society by restoring people to personal strength, ability, competence, confidence, stability, responsibility and spiritual well-being. Psychiatric drugs and psychiatric treatments are not workable.

Find out more about psychiatric drug side effects by clicking here.

 

 

 

 

 

 

 

 

Friday, March 04, 2011

Psychiatric Drugs and Violence: A Review of FDA Data Finds A Link

Mad in America

History, Science, and the Treatment of Psychiatric Disorders

by Robert Whitaker

Psychiatric Drugs and Violence: A Review of FDA Data Finds A Link

Antidepressants near top of list of drugs associated with violence

There has been an enduring controversy over whether psychiatric medications can trigger violent actions toward others. A review of the FDA's Adverse Event Reporting System  by Thomas Moore, Joseph Glenmullen and Curt Furberg, which was published by PLoS One on December 15, found that such "adverse events" are indeed associated with antidepressants and several other types of psychotropic medications.

To do their study, Moore and his collaborators extracted all serious events reports from the FDA's database from 2004 through September 2009, and then identified 484 drugs that had triggered at least 200 case reports of serious adverse events (of any type) during that 69-month period. They then investigated to see if any of these 484 drugs had a "disproportionate" association with violence. They identified 31 such drugs, out of the 484, that met this criteria.

The 31 "suspect" drugs accounted for 1527 of the 1937 case reports of violence toward others in the FDA database for that 69-month period. The drugs in that list of 31 included varenicline (an aid to smoking cessation), 11 antidepressants, 6 hypnotic/sedatives, and 3 drugs for attention deficit hyperactivity disorder. Antidepressants were responsible for 572 case reports of violence toward others; the three ADHD drugs for 108; and the hypnotic/sedatives for 97.

Of the 1937 total case reports of violence toward others, there were 387 cases of homicide, 404 physical assaults, 27 cases of physical abuse, 896 reports of homicidal ideation, and 223 cases of "violence related symptoms."

The adverse events reported to the FDA are known to represent but a tiny fraction of all such adverse events. This study simply identified 31 drugs responsible for most of the FDA case reports of violence toward others, with antidepressants near the top of that list.

In light of this finding, the many past shootings at school campuses and other public venues should perhaps be investigated anew by government officials, with an eye toward ascertaining whether psychotropic use may have, in the manner of an adverse event, triggered that violence.

Moore and his collaborators concluded: "These data provide new evidence that acts of violence towards others are a genuine and serious adverse drug event that is associated with a relatively small group of drugs. Varenicline, which increases the availability of dopamine, and serotonin reuptake inhibitors were the most strongly and consistently implicated drugs."

 

And more here:

 

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0015337

Prescription Drugs Associated with Reports of Violence Towards Others

Violence towards others is a seldom-studied adverse drug event and an atypical one because the risk of injury extends to others.

To identify the primary suspects in adverse drug event reports describing thoughts or acts of violence towards others, and assess the strength of the association.

From the Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) data, we extracted all serious adverse event reports for drugs with 200 or more cases received from 2004 through September 2009. We identified any case report indicating homicide, homicidal ideation, physical assault, physical abuse or violence related symptoms.

Disproportionality in reporting was defined as a) 5 or more violence case reports, b) at least twice the number of reports expected given the volume of overall reports for that drug, c) a χ2 statistic indicating the violence cases were unlikely to have occurred by chance (p<0.01).

We identified 1527 cases of violence disproportionally reported for 31 drugs. Primary suspect drugs included varenicline (an aid to smoking cessation), 11 antidepressants, 6 sedative/hypnotics and 3 drugs for attention deficit hyperactivity disorder. The evidence of an association was weaker and mixed for antipsychotic drugs and absent for all but 1 anticonvulsant/mood stabilizer. Two or fewer violence cases were reported for 435/484 (84.7%) of all evaluable drugs suggesting that an association with this adverse event is unlikely for these drugs.

Acts of violence towards others are a genuine and serious adverse drug event associated with a relatively small group of drugs. Varenicline, which increases the availability of dopamine, and antidepressants with serotonergic effects were the most strongly and consistently implicated drugs. Prospective studies to evaluate systematically this side effect are needed to establish the incidence, confirm differences among drugs and identify additional common features.